Amorsa Therapeutics Competitors and Similar CompaniesClear all
Amorsa Therapeutics's competitors and similar companies include Neurim Pharmaceuticals, Shionogi, Supernus Pharmaceuticals and Suven Life Sciences.
 Amorsa Therapeutics Amorsa is a neuropharmaceutical company engaged in the development and commercialization of treatments for central nervous system disorders including depression, anxiety, pain, and Rett Syndrome. |  Neurim Pharmaceuticals Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. | |
Founding Date | Founding Date 2013 | Founding Date 1991 | Founding Date 1878 | Founding Date 2005 | Founding Date 1989 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Southborough, US HQ | Locations Tel Aviv-Yafo, IL HQ Zug, CH | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Rockville, US HQ | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US |
Employees | Employees 1 | Employees 20 | Employees 4,955 | Employees 6527% increase | Employees 141 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 12.3 b | Valuation ($) 1.9 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $719m (FY, 2025) | Revenue (est.) ₹71.1m (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥55.5b (FY, 2026) | Cost of goods $74.6m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥491.3b (FY, 2026) | Gross profit $644.4m (FY, 2025) | Gross profit ₹210.4m (FY, 2026) |
Net income | Net income N/A | Net income N/A | Net income ¥205.9b (FY, 2026) | Net income ($38.6m) (FY, 2025) | Net income (₹2.8b) (FY, 2026) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised $ 69.5m | Total funding raised $ 32m |
For sources of this data, please see the company profile
View Company Profiles
Neurim Pharmaceuticals
HQ
Tel Aviv-Yafo, IL
Employees
20
Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
View companyShionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companySupernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companySuven Life Sciences
HQ
Hyderabad, IN
Employees
141
Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS.
View company